Biosensors International Group, Ltd. and BlueSail Medical (Biosensors or the “Company”, stock exchange code 002382.SZ), a developer, manufacturer and marketer of innovative medical devices, announced today that primary endpoint results of the LEADERS FREE II trial were presented at the TCT 2018 conference in San Diego, CA, USA.
September 28, 2018
· 3 min read